ASKA Pharmaceutical Holdings Co (TSE:4886) Total Stockholders Equity : 円60,390 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co Total Stockholders Equity?

ASKA Pharmaceutical Holdings Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was 円60,390 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. ASKA Pharmaceutical Holdings Co's Book Value per Share for the quarter that ended in Dec. 2023 was 円2,135.19. The ratio of a company's debt over equity can be used to measure how leveraged this company is. ASKA Pharmaceutical Holdings Co's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.17.

ASKA Pharmaceutical Holdings Co Total Stockholders Equity Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co Total Stockholders Equity Chart

ASKA Pharmaceutical Holdings Co Annual Data

Trend

Mar22

Mar23

Mar24

Total Stockholders Equity

48,891.00

54,531.00

61,929.00

ASKA Pharmaceutical Holdings Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial							54,531.00	56,878.00	58,619.00	60,390.00	61,929.00

ASKA Pharmaceutical Holdings Co (TSE:4886) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

ASKA Pharmaceutical Holdings Co's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(60390	-	0)	/	28.2832
	=	2,135.19

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

ASKA Pharmaceutical Holdings Co's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3180	+	6925)	/	60390
	=	0.17

ASKA Pharmaceutical Holdings Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of ASKA Pharmaceutical Holdings Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532

Website

https://www.aska-pharma-hd.co.jp

ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines

No Headlines